Icosavax, Inc. ICVX
We take great care to ensure that the data presented and summarized in this overview for Icosavax, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in ICVX
Top Purchases
Top Sells
About ICVX
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; IVX-A12, a respiratory syncytial virus (RSV) monovalent antigen candidate with RSV/human metapneumovirus (hMPV) bivalent target indication; IVX-241, a vaccine candidate with hMPV target; and IVX-411, an original receptor binding domain (RBD) sequence antigen with SARS-CoV-2 target indication and is under Phase 1/2 clinical trial. The company was incorporated in 2017 and is headquartered in Seattle, Washington.
Insider Transactions at ICVX
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 19
2024
|
Ra Capital Management, L.P. |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
5,969,108
-100.0%
|
-
|
|
Feb 19
2024
|
Adam K. Simpson |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
783,108
-100.0%
|
-
|
|
Feb 19
2024
|
Adam K. Simpson |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
358,657
-100.0%
|
-
|
|
Feb 19
2024
|
Cassia Cearley |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
131,799
-100.0%
|
-
|
|
Feb 19
2024
|
Ann M Veneman |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,834
-100.0%
|
-
|
|
Feb 19
2024
|
Ann M Veneman |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
11,209
-100.0%
|
-
|
|
Feb 19
2024
|
Heidi Fields |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,917
-100.0%
|
-
|
|
Feb 19
2024
|
Heidi Fields |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
11,376
-100.0%
|
-
|
|
Feb 19
2024
|
John W. Shiver |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,833
-100.0%
|
-
|
|
Feb 19
2024
|
John W. Shiver |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
8,066
-100.0%
|
-
|
|
Feb 19
2024
|
Thomas Joseph Russo |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
39,367
-100.0%
|
-
|
|
Feb 19
2024
|
Jim Wassil |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,392
-100.0%
|
-
|
|
Feb 19
2024
|
Jim Wassil |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
3,695
-100.0%
|
-
|
|
Feb 19
2024
|
Mark Mcdade |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
3,510,228
-100.0%
|
-
|
|
Feb 19
2024
|
Mark Mcdade |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
55,786
-100.0%
|
-
|
|
Feb 19
2024
|
Niranjan Kanesa Thasan |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
223,980
-100.0%
|
-
|
|
Feb 01
2024
|
Adam K. Simpson |
SELL
Open market or private sale
|
Direct |
15,000
-4.01%
|
$225,000
$15.29 P/Share
|
|
Feb 01
2024
|
Adam K. Simpson |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+3.86%
|
$15,000
$1.04 P/Share
|
|
Feb 01
2024
|
Adam K. Simpson |
SELL
Bona fide gift
|
Indirect |
6,532
-1.23%
|
-
|
|
Jan 22
2024
|
Adam K. Simpson |
BUY
Exercise of conversion of derivative security
|
Direct |
98,016
+11.2%
|
$0
$0.94 P/Share
|
Last 12 Months Summary
| Exercise of conversion of derivative security | 313K shares |
|---|
| Sale (or disposition) back to the issuer | 16K shares |
|---|---|
| Disposition due to a tender of shares in a change of control transaction | 11.1M shares |
| Bona fide gift | 6.53K shares |
| Open market or private sale | 272K shares |